13.87USDMkt Cap: 2.22B USDP/E: —Last update: 2026-05-21
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a su…
Industry Peers
Diagnostics & Researchloading…
Indicators:|
Key Statistics
Company
Market Cap2.22B USD
Enterprise Value2.22B USD
Revenue (TTM)295.41M USD
Gross Profit205.62M USD
Net Income (TTM)-59.50M USD
Revenue/Share1.927 USD
Last Price13.87 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees624
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS00650F1093
Valuation
P/E (Trailing)—
P/E (Forward)-53.94
PEG—
EV/EBITDA-74.45
EV/Revenue7.51
P/S7.51
P/B10.24
EPS (TTM)-0.32
EPS (Forward)-0.26
52W Range
13.3991% of range13.91
52W High13.91 USD
52W Low13.39 USD
Profitability
Gross Margin74.24%
Oper. Margin-27.10%
EBITDA Margin-10.08%
Profit Margin-21.48%
ROE-27.19%
ROA-11.60%
Growth
Revenue Growth35.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-45.99M USD
CapEx (TTM)2.96M USD
FCF Margin5.45%
FCF Yield0.73%
Net Debt-10.15M USD
Net Debt/EBITDA0.34
Balance Sheet
Debt/Equity0.36
Current Ratio3.35
Quick Ratio3.08
Book Value/Sh1.355 USD
Cash/Share1.364 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Target (Mean)20.14 USD
Target Range18.00 USD – 22.00 USD
# Analysts7
Ownership
Shares Out.160.04M
Float125.37M
Insiders1.84%
Institutions96.53%
Short Interest
Short Ratio5.2d
Short % Float6.66%
Short % Out.5.27%
Shares Short8.44M
Short (prev mo.)8.56M
Technical
SMA 5013.79 (+0.6%)
SMA 20015.11 (-8.2%)
Beta2.16
S&P 52W Chg28.31%
Avg Vol (30d)1.08M
Avg Vol (10d)1.45M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—